Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Meridian Holdings
Market Cap: US$1.4m
Through its subsidiaries, provides healthcare management and information system solutions in the United States.
MRDH
US$0.0092
7D
0%
1Y
n/a
CBD Life Sciences
Market Cap: US$1.4m
Engages in the development and marketing a line of cannabidiol based organic products.
CBDL
US$0.0005
7D
42.9%
1Y
-92.5%
MyndTec
Market Cap: CA$1.9m
A medical technology company, researches, develops, and distributes therapies for individuals with paralysis due to stroke or spinal cord injury in Canada and the United States.
MYTC
CA$0.08
7D
0%
1Y
-20.0%
Know Labs
Market Cap: US$1.4m
Focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States.
KNW
US$0.48
7D
3.7%
1Y
-98.3%
CardioComm Solutions
Market Cap: CA$1.9m
Develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide.
EKG
CA$0.01
7D
0%
1Y
0%
LiveCare
Market Cap: US$1.4m
Focuses on addressing the diabetic epidemic and other chronic diseases through state-of-the-art technologies and a human-touch approach.
LVCE
US$0.022
7D
0%
1Y
n/a
Hexima
Market Cap: AU$2.2m
Does not have significant operations.
HXL
AU$0.013
7D
0%
1Y
-18.8%
Avenir Wellness Solutions
Market Cap: US$1.4m
Through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness.
AVRW
US$0.015
7D
38.9%
1Y
-65.8%
INVO Fertility
Market Cap: US$1.3m
A life science portfolio company, develops clinical stage assets to treat patients with fertility, oncology, and autoimmune diseases.
IVF
US$1.96
7D
-9.3%
1Y
n/a
Hepion Pharmaceuticals
Market Cap: US$1.3m
A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States.
HEPA
US$0.13
7D
-67.9%
1Y
-99.8%
Acura Pharmaceuticals
Market Cap: US$1.3m
An innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States.
ACUR
US$0.02
7D
0%
1Y
525.0%
Comprehensive Healthcare Systems
Market Cap: CA$1.8m
Provides healthcare administrative software solutions in the United States.
CHS
CA$0.20
7D
0%
1Y
0%
Halberd
Market Cap: US$1.3m
A biotech company, develops treatments for neurodegenerative diseases.
HALB
US$0.0022
7D
29.4%
1Y
-71.8%
InVitro International
Market Cap: US$1.3m
Develops test kits for non-animal testing applications in the United States and internationally.
IVRO
US$0.06
7D
-10.8%
1Y
-4.8%
Vaxxinity
Market Cap: US$1.3m
A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.
VAXX
US$0.01
7D
4,900.0%
1Y
-82.0%
AdAlta
Market Cap: AU$1.9m
A clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.
1AD
AU$0.003
7D
-25.0%
1Y
-87.5%
Non-Invasive Monitoring Systems
Market Cap: US$1.2m
Does not have significant operations.
NIMU
US$0.008
7D
100.0%
1Y
-32.2%
Certive Solutions
Market Cap: CA$1.8m
Provides revenue cycle consultative services and solutions in the United States.
CBP
CA$0.01
7D
0%
1Y
-66.7%
Processa Pharmaceuticals
Market Cap: US$1.2m
A clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment.
PCSA
US$0.25
7D
-9.9%
1Y
-87.6%
Shortwave Life Sciences
Market Cap: UK£871.8k
Through its subsidiary, Blossom Analysis, provides a data and insights platform for the psychedelic healthcare industry.
PSY
UK£0.003
7D
0%
1Y
-89.7%
Rimrock Gold
Market Cap: US$1.2m
Through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts.
RMRK
US$0.0003
7D
-25.0%
1Y
-25.0%
Adastra Holdings
Market Cap: CA$1.6m
Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.
XTRX
CA$0.28
7D
-14.9%
1Y
-86.1%
Bespoke Extracts
Market Cap: US$1.1m
Together with its subsidiary, Bespoke Extracts Colorado, LLC, produces and sells pre-rolled marijuana cigarettes in the United States.
BSPK
US$0.10
7D
-11.0%
1Y
2.3%
Silo Wellness
Market Cap: CA$1.5m
A psychedelics and wellness company, develops psychedelic medicine to reduce trauma.
SILO
CA$0.01
7D
0%
1Y
-33.3%
PreAxia Health Care Payment Systems
Market Cap: US$1.1m
Focuses on the development, distribution, marketing, and sale of health care payment processing services and products.
PAXH
US$0.057
7D
0%
1Y
n/a
SCWorx
Market Cap: US$1.1m
Engages in the provision of data content and services related to the repair, normalization and interoperability of information for healthcare providers in the United States.
WORX
US$0.52
7D
-4.9%
1Y
-76.2%
SPO Global
Market Cap: US$1.1m
Does not have significant operations.
SPOM
US$0.0007
7D
-12.5%
1Y
-81.1%
Captor Capital
Market Cap: CA$1.5m
Engages in the retail sale of cannabis products in the United States.
CPTR
CA$0.45
7D
-16.0%
1Y
-25.8%
Dakshidin Corporation
Market Cap: US$1.1m
Through its subsidiaries, operates as a CBD/cannabis-based medical product company.
DKSC
US$0.0003
7D
0%
1Y
-70.0%
New Leaf Ventures
Market Cap: CA$1.5m
Engages in processing, packaging, marketing, and distributing cannabis and related products.
NLV
n/a
7D
n/a
1Y
n/a
NanoVibronix
Market Cap: US$1.1m
Through its subsidiaries, focuses on non-invasive biological response-activating devices that target wound healing and pain therapy and can be administered at home, without the assistance of medical professionals.
NAOV
US$1.43
7D
-65.3%
1Y
-82.8%
Rize Oncology
Market Cap: CA$1.5m
Engages in the development of oncology therapeutics.
RIZE
CA$0.02
7D
0%
1Y
-63.6%
Regen BioPharma
Market Cap: US$1.1m
Focuses on the development of regenerative medical applications in the United States.
RGBP
US$0.05
7D
-25.2%
1Y
-85.8%
CYduct Diagnostics
Market Cap: US$1.1m
A healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions.
CYDX
US$0.20
7D
0%
1Y
-42.0%
TransCanna Holdings
Market Cap: CA$1.4m
Through its subsidiaries, engages in the manufacturing, transportation, and distribution of cannabis related products in the United States.
TCAN
CA$0.01
7D
0%
1Y
-90.0%
Target Group
Market Cap: US$1.0m
Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.
CBDY
US$0.0017
7D
-9.6%
1Y
-71.2%